| Sleep Disorders |
1 |
1 |
| Insomnia |
0 |
0.67 |
| Sleep |
0 |
0.67 |
| Obstructive Sleep Apnea |
0 |
0.5 |
| Cognitive Behavioral Therapy |
0 |
0.18 |
| Food and Drug Administration (FDA) |
0 |
0.15 |
| Receptors |
0 |
0.15 |
| Hypnotic Drug |
0 |
0.09 |
| Sleep Apnea |
0 |
0.07 |
| Cognitive Impairment |
0 |
0.06 |
| Concerns of Elderly |
0 |
0.06 |
| Geriatrics |
0 |
0.06 |
| Impairment |
0 |
0.06 |
| Sedative |
0 |
0.06 |
| Headache |
0 |
0.04 |
| Mild Cognitive Impairment |
0 |
0.04 |
| Patient Safety |
0 |
0.04 |
| Social Determinants of Health |
0 |
0.04 |
| Adverse Effects |
0 |
0.03 |
| California |
0 |
0.03 |
| Hypothalamus |
0 |
0.03 |
| Narcolepsy |
0 |
0.03 |
| Neuron |
0 |
0.03 |
| Polypharmacy |
0 |
0.03 |
| Socioeconomics |
0 |
0.03 |
| Tolerance |
0 |
0.03 |